Non-HDL cholesterol and apoB in dyslipidaemia.

نویسندگان

  • Allan D Sniderman
  • Jean-Charles Hogue
  • Jean Bergeron
  • Claude Gagné
  • Patrick Couture
چکیده

On the basis of a high correlation, non-HDL-C (non-high-density lipoprotein cholesterol) and apoB (apolipoprotein B) have been suggested to be of equivalent value for clinical practice; however, the strength of this relationship has not been examined in detail in patients with dyslipidaemia. The present study examines the variance of non-HDL-C compared with apoB in 1771 consecutive patients evaluated in a lipid clinic. These patients were divided into normolipidaemic subjects (n=407), type I hyperlipoproteinaemia (n=16), type IIa (n=736) and IIb (n=231) hyperlipoproteinaemia, type III hyperlipoproteinaemia (n=38), type IV hyperlipoproteinaemia (n=509) and type V hyperlipoproteinaemia (n=101). The relationship between non-HDL-C and apoB was examined both in terms of correlation and concordance. Correlation was high, but concordance was only moderate in the normolipidaemic subjects and in those with type IIa and type IIb hyperlipoproteinaemia. Correlation and concordance were both low in the subgroups with type III and type V hyperlipoproteinaemia. In those with type IV hyperlipoproteinaemia, correlation was moderately high (r=0.74), but concordance was only fair. In conclusion, our results indicate that there is substantial variance of apoB for given values of non-HDL-C in many dyslipidaemic subjects. It follows that correlation is not adequate as a sole judge of equivalence of laboratory parameters.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Ethnic Difference in Lipid Profiles

Dyslipidaemia is a major cardiovascular disease (CVD) risk factor that plays an important role in the progress of atherosclerosis, the underlying pathology of CVD. To keep lipids and lipoproteins levels within ideal range has been recommended by different national, regional, or global (2001; Graham et al. 2007; World Health Organization 2007) guidelines on the prevention and management of CVD. ...

متن کامل

Non-HDL cholesterol versus apolipoprotein B in diabetic dyslipoproteinemia: alternatives and surrogates versus the real thing.

D yslipidemia in patients with diabetes has suddenly emerged as a vital clinical issue. Whereas better glucose control has not been shown to significantly reduce vascular mortality and morbidity (1), lowering LDL cholesterol has regularly been associated with substantial benefit. This may be just the beginning; fibrate therapy also holds promise (2). The Adult Treatment Panel III (ATPIII) reaff...

متن کامل

Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.

OBJECTIVE To evaluate the role of non-HDL cholesterol and apolipoprotein (apo)B, markers of all potentially atherogenic lipoproteins, as predictors of cardiovascular disease (CVD) in comparison with LDL cholesterol in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS We prospectively followed 746 diabetic men in the Health Professionals' Follow-up Study who were aged 46-81 years and ...

متن کامل

Relationship between dyslipidaemia and glycaemic status in patients with Type 2 diabetes mellitus.

The risk of coronary heart disease (CHD) is dramatically increased in diabetic patients due to their atherogenic lipid profile. The severity of CHD in diabetic patients has been found to be directly associated with glycated haemoglobin (HbA1c). According to the Malaysian Clinical Practice Guidelines on diabetes mellitus (DM), HbA1c level less than 6.5% reduces the risk of microvascular and macr...

متن کامل

Non-high-density Lipoprotein Cholesterol versus Apolipoprotein B as Predictors for Coronary Heart Disease

Recently non high density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B (apoB) have been found to be better and more reliable markers of atherosclerotic risk than LDL-C (low density lipoprotein cholesterol).Very few studies, as of now, are available in India which compared their predictability as a cardiovascular risk marker. The aim of our study was to evaluate and compare apoB and ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Clinical science

دوره 114 2  شماره 

صفحات  -

تاریخ انتشار 2008